207 related articles for article (PubMed ID: 31682303)
1. MarR family proteins are important regulators of clinically relevant antibiotic resistance.
Beggs GA; Brennan RG; Arshad M
Protein Sci; 2020 Mar; 29(3):647-653. PubMed ID: 31682303
[TBL] [Abstract][Full Text] [Related]
2. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery.
Piddock LJV
J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis.
Jin M; Lu J; Chen Z; Nguyen SH; Mao L; Li J; Yuan Z; Guo J
Environ Int; 2018 Nov; 120():421-430. PubMed ID: 30125859
[TBL] [Abstract][Full Text] [Related]
4. The multiple antibiotic resistance regulator MarR is a copper sensor in Escherichia coli.
Hao Z; Lou H; Zhu R; Zhu J; Zhang D; Zhao BS; Zeng S; Chen X; Chan J; He C; Chen PR
Nat Chem Biol; 2014 Jan; 10(1):21-8. PubMed ID: 24185215
[TBL] [Abstract][Full Text] [Related]
5. Restoring colistin sensitivity in colistin-resistant E. coli: Combinatorial use of MarR inhibitor with efflux pump inhibitor.
Sundaramoorthy NS; Suresh P; Selva Ganesan S; GaneshPrasad A; Nagarajan S
Sci Rep; 2019 Dec; 9(1):19845. PubMed ID: 31882661
[TBL] [Abstract][Full Text] [Related]
6. A Major Facilitator Superfamily (MFS) Efflux Pump, SCO4121, from Streptomyces coelicolor with Roles in Multidrug Resistance and Oxidative Stress Tolerance and Its Regulation by a MarR Regulator.
Nag A; Mehra S
Appl Environ Microbiol; 2021 Mar; 87(7):. PubMed ID: 33483304
[TBL] [Abstract][Full Text] [Related]
7. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
9. The MarR repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli: prototypic member of a family of bacterial regulatory proteins involved in sensing phenolic compounds.
Sulavik MC; Gambino LF; Miller PF
Mol Med; 1995 May; 1(4):436-46. PubMed ID: 8521301
[TBL] [Abstract][Full Text] [Related]
10. In search of natural substrates and inhibitors of MDR pumps.
Lewis K
J Mol Microbiol Biotechnol; 2001 Apr; 3(2):247-54. PubMed ID: 11321580
[TBL] [Abstract][Full Text] [Related]
11. Role of LsrR in the regulation of antibiotic sensitivity in avian pathogenic Escherichia coli.
Yu L; Li W; Li Q; Chen X; Ni J; Shang F; Xue T
Poult Sci; 2020 Jul; 99(7):3675-3687. PubMed ID: 32616264
[TBL] [Abstract][Full Text] [Related]
12. Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.
Laudy AE
Pol J Microbiol; 2018 Jun; 67(2):129-135. PubMed ID: 30015451
[TBL] [Abstract][Full Text] [Related]
13. Optimization of a novel series of pyranopyridine RND efflux pump inhibitors.
Aron Z; Opperman TJ
Curr Opin Microbiol; 2016 Oct; 33():1-6. PubMed ID: 27232955
[TBL] [Abstract][Full Text] [Related]
14. Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.
Arshad M; Goller CC; Pilla D; Schoenen FJ; Seed PC
J Infect Dis; 2016 Apr; 213(8):1330-9. PubMed ID: 26671885
[TBL] [Abstract][Full Text] [Related]
15. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump.
Ohene-Agyei T; Mowla R; Rahman T; Venter H
Microbiologyopen; 2014 Dec; 3(6):885-96. PubMed ID: 25224951
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
Mowla R; Wang Y; Ma S; Venter H
Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
[TBL] [Abstract][Full Text] [Related]
17. The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach.
Abdel-Halim H; Al Dajani A; Abdelhalim A; Abdelmalek S
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6309-6318. PubMed ID: 31209525
[TBL] [Abstract][Full Text] [Related]
18. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV
Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional analysis reveals the critical role of RNA polymerase-binding transcription factor, DksA, in regulating multi-drug resistance of Escherichia coli.
Wang J; Cao L; Yang X; Wu Q; Lu L; Wang Z
Int J Antimicrob Agents; 2018 Jul; 52(1):63-69. PubMed ID: 29746997
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
Laudy AE; Kulińska E; Tyski S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
